Paul Hermonat, Ph.D.

Professor of Internal Medicine

Education

University of Florida, Gainesville, College of Medicine,
Department of Immunology and Medical Microbiology
Ph.D. (1980-1984)

University of New Hampshire, Durham
BS, Biochemistry (1970-1974)

Training

Research Associate, Dept. of Immunology & Infectious Diseases
School of Hygiene,
Johns Hopkins University
Baltimore, MD (1988-1990)
 

Postdoc, Laboratory of Tumor Virus Biology
National Cancer Institute
Bethesda, MD (1985-1988)

Honors/Memberships

American Society for Microbiology

American Society for Virology

Arkansas Cancer Research Center

American Association for Advanced Sciences

Associate Member of American Society of Clinical Pathologists

Patents and Inventions

U.S. Patent 5,139,941 (1992): “AAV Transduction Vectors”. Co-inventors: P.L. Hermonat, K.I,Berns, J.R. Samulski, N. Muzyczka, patent based on Hermonat, et al PNAS 81:6466

U.S. Patent 6,153,436 (2000): “A method of human gene therapy using wild type adeno-associated viral (AAV) vectors”. Hermonat et al.

U.S. Patent allowed (2002): “Productive replication of HPV in trophoblasts, for diagnostics, drug testing, and the study of HPV biology”. Hermonat et al.

U.S. Patent applied: “The Rep78 protein/gene of adeno-associated virus for use in gene therapy and anticancer treatments”. Hermonat et al.

U.S. Patent applied: “Immunotherapy by AAV-based genetic alteration of dendritic cells”. Hermonat et al.

U.S. Patent applied: “Adeno-associated viral Rep78 major regulatory protein, mutants there of and uses thereof”. Hermonat et al.

U.S. Patent applied: “Production of AAV by autonomous replication in skin raft”. Hermonat and Meyers

U.S. Patent applied: “Immunotherapy by dendritic cell protein pulsing”. Parham et al.